BetterScholar BetterScholar

P. Marks

New England Journal of Medicine, Journal of Clinical Investigation, Mayo Clinic proceedings, Blood Cancer Discovery, MMWR. Morbidity and mortality weekly report, Seminars in hematology, Nature Communications Show more
10
Role
Title
Level Year L/R
🐜 Early safety indicators of COVID-19 convalescent plasma in 5,000 patients.
36 auth. M. Joyner, R. Wright, D. Fairweather, Jonathon W. Senefeld, K. A. Bruno, S. Klassen, R. Carter, A. Klompas, C. Wiggins, J. Shepherd, R. Rea, E. Whelan, A. Clayburn, Matthew R. Spiegel, Patrick W. Johnson, ... E. Lesser, S. Baker, K. Larson, J. Ripoll, K. Andersen, D. Hodge, K. Kunze, M. Buras, M. Vogt, V. Herasevich, J. Dennis, R. Regimbal, P. Bauer, J. Blair, C. V. van Buskirk, J. Winters, J. Stubbs, N. Paneth, N. Verdun, P. Marks, A. Casadevall 		8 2020
8
🐜
🐜 Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
40 auth. M. Joyner, R. Carter, Jonathon W. Senefeld, S. Klassen, J. Mills, Patrick W. Johnson, E. Theel, C. Wiggins, K. A. Bruno, A. Klompas, E. Lesser, K. Kunze, M. Sexton, J. D. Diaz Soto, S. Baker, ... J. Shepherd, N. van Helmond, N. Verdun, P. Marks, C. V. van Buskirk, J. Winters, J. Stubbs, R. Rea, D. Hodge, V. Herasevich, E. Whelan, A. Clayburn, K. Larson, J. Ripoll, K. Andersen, M. Buras, M. Vogt, J. Dennis, R. Regimbal, P. Bauer, J. Blair, N. Paneth, D. Fairweather, R. Wright, A. Casadevall 		8 2021
8
🐜
🐜 Safety Update
40 auth. M. Joyner, K. A. Bruno, S. Klassen, K. Kunze, Patrick W. Johnson, E. Lesser, C. Wiggins, Jonathon W. Senefeld, A. Klompas, D. Hodge, J. Shepherd, R. Rea, E. Whelan, A. Clayburn, Matthew R. Spiegel, ... S. Baker, K. Larson, J. Ripoll, K. Andersen, M. Buras, M. Vogt, V. Herasevich, J. Dennis, R. Regimbal, P. Bauer, J. Blair, C. V. van Buskirk, J. Winters, J. Stubbs, N. van Helmond, B. Butterfield, M. Sexton, J. D. Diaz Soto, N. Paneth, N. Verdun, P. Marks, A. Casadevall, D. Fairweather, R. Carter, R. Wright 		7 2020
7
🐜
🦁 Clarifying Stem-Cell Therapy's Benefits and Risks.
P. Marks, C. Witten, R. Califf 		7 2016
7
🦁
🐜 Scalable Manufacturing of CAR T cells for Cancer Immunotherapy.
9 auth. M. Abou-el-Enein, Magdi Elsallab, S. Feldman, A. Fesnak, H. Heslop, P. Marks, ... B. Till, G. Bauer, B. Savoldo 		6 2021
6
🐜
🦁 Balancing Safety and Innovation for Cell-Based Regenerative Medicine.
P. Marks, S. Gottlieb 		6 2018
6
🦁
🐜 Screening of Blood Donations for Zika Virus Infection - Puerto Rico, April 3-June 11, 2016.
17 auth. M. Kuehnert, S. Basavaraju, R. Moseley, L. Pate, S. Galel, P. Williamson, M. Busch, J. Alsina, C. Climent-Peris, P. Marks, ... J. Epstein, H. Nakhasi, J. Hobson, D. Leiby, P. Akolkar, L. Petersen, Brenda Rivera-García 		6 2016
6
🐜
🐢 Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy.
N. Verdun, P. Marks 		6 2024
6
🐢
🦁 Hematologic manifestations of liver disease.
P. Marks 		6 2013
6
🦁
🐜 Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
39 auth. K. Kunze, P. Johnson, N. van Helmond, J. Senefeld, M. M. Petersen, S. Klassen, C. Wiggins, A. Klompas, K. A. Bruno, J. Mills, E. Theel, M. Buras, M. Golafshar, M. Sexton, J. D. Diaz Soto, ... S. Baker, J. Shepherd, N. Verdun, P. Marks, N. Paneth, D. Fairweather, R. Wright, C. V. van Buskirk, J. Winters, J. Stubbs, R. Rea, V. Herasevich, E. Whelan, A. Clayburn, K. Larson, J. Ripoll, K. Andersen, E. Lesser, M. Vogt, J. Dennis, R. Regimbal, P. Bauer, J. Blair, Casadeva 		5 2021
5
🐜